Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo
about
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Idiosyncratic adverse drug reactions: current conceptsPharmacogenomics of off-target adverse drug reactions.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy miceThe pharmacogenomics of HIV therapy.Immunological principles of T-cell-mediated adverse drug reactions in skin.Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism.An Adverse Drug Reaction to Trimethoprim-Sulfamethoxazole Revealing Primary HIV: A Case Report and Literature Review.Role of bioactivation in drug-induced hypersensitivity reactions.Concepts in molecular dermatotoxicology.Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology.Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity."Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cellsIn vitro tests of T cell-mediated drug hypersensitivity.Severe drug eruptions revisited.HLA and pharmacogenetics of drug hypersensitivity.The generation, detection, and effects of reactive drug metabolites.Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infectionThe p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors.Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds.T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells.HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.Personalized medicine for HLA-associated drug-hypersensitivity reactions
P2860
Q26800976-904A0B70-DBFA-46EA-BD59-45A28D370147Q26800980-B4AE2827-F243-43CA-9B63-8CB6F0910481Q26824391-398F99EB-81C7-4B47-8FC1-9AD80BD7A7C4Q30400366-70EBF887-1682-4725-BCAF-4C8FC925CD6BQ33777950-E0972EBD-6094-45A0-977F-01C3EA5A42AFQ34020879-361E507A-068F-471C-93E9-252251E62EB6Q34429315-3837CECF-9A4A-4C7D-B321-44D3F5B9A26DQ34574033-D4948CA5-5614-44B9-9D40-B936F239107EQ34609440-58950D7B-7F5C-48AF-B120-351626252FBEQ34830063-9C20963A-DC2C-4F42-9A22-54950120C562Q34922937-585AA82F-E21F-48C1-9CB1-37767DBB4E6EQ36422872-98552B00-F077-4CDB-AB9B-7B807E768206Q36439187-94CA4471-D47F-4BBA-B068-60273F91F883Q36553701-7084B8C2-4DA8-40D5-8AB0-54B27ABED725Q36662875-36EBF812-67ED-4696-A2F3-C3AA7DD31F35Q36747900-B9B897B1-2372-4F33-A2BA-92F03F252EADQ37416416-4E1F42D0-1339-4217-B8ED-C7215831FBE8Q37754599-547D35A0-AAC5-432C-8F45-87900909D632Q37992545-07119FE9-0D10-4D94-B560-6787A7C09E62Q38037649-94E9A7EF-DC65-4A9A-90FE-8AC9A2674BCFQ38054629-72351E7F-CFDD-4201-84C1-A8C7EAD3F204Q38286229-E2B52BD3-88E4-4F71-B035-78CC41518CA9Q40502992-0CC72B37-CC09-46DE-AD5A-07759BAF245DQ40619738-A42B9BAC-F87B-4877-A57C-039AA541BDF6Q46820532-D862B422-0C40-4545-9A59-7873A6351050Q46879570-AEE5129C-5C55-49E5-9044-E32F2CE2DE43Q46919841-AB24D14E-DF4A-4B7A-8371-F36419021481Q47320133-C7EEF9FE-9132-4939-8625-1C8DFE444F3DQ50624617-F20C44BD-86A5-428A-B3B9-FB892DD9C2F7Q50699986-515C8860-2C01-404C-A590-52C117AEB3F1Q52837404-659B9325-034E-4211-8238-1F17F4185CB6Q57223243-0881820F-29F9-4A39-9B22-EF01B4D60EBB
P2860
Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@ast
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@en
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@nl
type
label
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@ast
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@en
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@nl
prefLabel
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@ast
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@en
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@nl
P2093
P2860
P921
P356
P1476
Antigenicity and immunogenicit ...... d T-cell proliferation in vivo
@en
P2093
C Burkhart
D J Naisbitt
S F Gordon
W J Pichler
P2860
P304
P356
10.1038/SJ.BJP.0704074
P407
P577
2001-05-01T00:00:00Z